EditorialOpen Access
The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters
Cureus · 31.10.2026
DOI: 10.7759/cureus.118912 ↗Kurz gefasst
Editorial in der Zeitschrift Cureus, erschienen am 31.10.2026. Verfasst von Arya Babul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences, West Career and Technical Academy, Las Vegas, USA. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
adolescentsbuprenorphinecascade of careepistemic injusticefentanyl eramedication accessopioid use disorderpediatric labelingregulatory barrierstreatment disparities
Autor:innen und Institutionen
- Biomedical Sciences, West Career and Technical Academy, Las Vegas, USA.
- Biomedical Sciences, Society for Awareness of Neglected Diseases, Las Vegas, USA.
- Drug Regulatory Affairs, Tavolar LLC, Las Vegas, USA.
Zitieren
APA
Babul, A., & Mahdavi, P. (2026). The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters. Cureus. https://doi.org/10.7759/cureus.118912
Vancouver
Babul A, Mahdavi P. The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters. Cureus. 2026. doi:10.7759/cureus.118912
BibTeX
@article{Babul2026,
author = {Babul, Arya and Mahdavi, Parisa},
title = {The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.118912}
}
EUVIMED